NuVasive reports $282M in Q2 revenue — Up 8.5%

Spinal Tech

NuVasive released its second quarter 2018 financial results.

Here's what you need to know:

1. The company experienced an 8.5 percent increase in year-over-year revenues, topping $281.6 million.

2. NuVasive's second quarter income sits at $11.5 million,or $0.22 per share.

3. NuVasive reported a gross profit of $204.5 million for the second quarter.

4. For full-year 2018, the company expects to see revenues range between $1.095 billion and $1.105 billion, reflecting a 6.7 percent to 7.6 percent year-over-year increase.

5. NuVasive anticipates its diluted earnings per share to range between $2.37 and $2.40.

To view the full report, click here.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers